​

Vivos Therapeutics Ownership | Who Owns Vivos Therapeutics?

OverviewForecastRevenueFinancialsChartTranscripts

Vivos Therapeutics Ownership Summary

Vivos Therapeutics is owned by 3.63% institutional investors, 26.35% insiders, and 70.02% retail investors. Vanguard group is the largest institutional shareholder, holding 2.77% of VVOS shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 1.58% of its assets in Vivos Therapeutics shares.

VVOS Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockVivos Therapeutics3.63%26.35%70.02%
SectorHealthcare Stocks 50.53%12.40%37.07%
IndustryMedical Device Stocks49.11%12.58%38.31%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Vanguard group304.16K2.77%$617.45K
Connective capital management200.00K2.20%$620.00K
Geode capital management85.00K0.58%$38.63K
Iht wealth management76.74K0.52%$34.88K
Vanguard capital management60.63K0.41%$27.59K
Commonwealth equity services42.50K0.29%$19.32K
Ubs group39.15K0.27%$17.82K
B. riley wealth advisors38.07K0.26%$18.77K
Centurion wealth management35.68K0.24%$16.22K
Blackrock funding, inc. /de27.82K0.19%$12.64K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Connective capital management200.00K0.57%$620.00K
Centurion wealth management35.68K0.00%$16.22K
Acorn wealth advisors14.78K0.00%$6.72K
B. riley wealth advisors38.07K0.00%$18.77K
Iht wealth management76.74K0.00%$34.88K
Sequoia financial advisors24.00K0.00%$10.91K
Tower research capital llc (trc)5.21K0.00%$2.37K
Drw securities---
Advisor group1.14K-$516.00
Commonwealth equity services42.50K-$19.32K

Top Buyers

HolderShares% AssetsChange
Vanguard group304.16K-212.70K
Connective capital management200.00K0.57%200.00K
Iht wealth management76.74K0.00%35.67K
Ubs group39.15K-28.11K
Susquehanna group, llp10.07K-10.07K

Top Sellers

HolderShares% AssetsChange
Armistice capital---1.12M
Anson funds management lp---242.58K
Vanguard capital management60.63K--212.70K
Drw securities---115.91K
Strategic wealth investment group---100.00K

New Positions

HolderShares% AssetsChangeValue
Connective capital management200.00K0.57%200.00K$620.00K
Susquehanna group, llp10.07K-10.07K$4.58K
Integrated wealth concepts320.00-320.00$144.00
Fmr40.00-40.00$124.00
Global retirement partners23.00-23.00$10.00

Sold Out

HolderChange
Citigroup-1.00
Northwestern mutual wealth management-3.00
Steward partners investment advisory-8.00
Raymond james financial-74.00
Group one trading-228.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 202622-4.35%531,027-70.86%32.34%6-45.45%4100.00%
Mar 31, 202612-33.33%194,649-70.42%14.93%4-42.86%2-33.33%
Dec 31, 202513-40.91%597,811-12.95%59.55%5-54.55%2-50.00%
Sep 30, 20252011.11%486,67821.04%524.47%10-4300.00%
Jun 30, 202517-15.00%401,289-23.45%412.55%9-25.00%1-

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv212.70K1.58%-
Fidelity Extended Market Index60.77K0.44%-
Vanguard Institutional Extnd Mkt Idx Tr60.63K0.42%-
Extended Equity Market Fund B27.82K0.27%-
Extended Equity Market Fund E27.82K0.27%-
Extended Equity Market Fund K23.68K0.23%-174.00
Blackrock Extended Mkt Fund CF27.82K0.20%-
Abante Quant Value FI26.77K0.20%-
BlackRock Extended Equity Market Fund K23.64K0.17%-43.00
NT Ext Equity Mkt Index Fund - NL15.07K0.11%8.26K

Recent Insider Transactions

DateNameRoleActivityValue
Jun 30, 2026Skaff Michael C-Buy$391.78K
Jun 30, 2026Skaff Michael C-Buy$861.91K
Jun 30, 2026Skaff Michael C-Buy$1.25M
Mar 31, 2026Skaff Michael C-Buy$413.86K
Mar 31, 2026Skaff Michael C-Buy$1.94M

Insider Transactions Trends

DateBuySell
2026 Q15-
2025 Q2--
2024 Q4--
2024 Q2--
2023 Q25-

VVOS Ownership FAQ

Who Owns Vivos Therapeutics?

Vivos Therapeutics shareholders are primarily institutional investors at 3.63%, followed by 26.35% insiders and 70.02% retail investors. The average institutional ownership in Vivos Therapeutics's industry, Medical Device Stocks, is 49.11%, which Vivos Therapeutics falls below.

Who owns the most shares of Vivos Therapeutics?

Vivos Therapeutics’s largest shareholders are Vanguard group (304.16K shares, 2.77%), Connective capital management (200K shares, 2.20%), and Geode capital management (85K shares, 0.58%). Together, they hold 5.56% of Vivos Therapeutics’s total shares outstanding.

Does Blackrock own Vivos Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Vivos Therapeutics.

Who is Vivos Therapeutics’s biggest shareholder by percentage of total assets invested?

Connective capital management is Vivos Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.57% of its assets in 200K Vivos Therapeutics shares, valued at 620K$.

Who is the top mutual fund holder of Vivos Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Vivos Therapeutics shares, with 1.58% of its total shares outstanding invested in 212.7K Vivos Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools